These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17642861)

  • 1. Ketoconazole 2% shampoo in pityriasis versicolor: an open trial.
    Rathi SK
    Indian J Dermatol Venereol Leprol; 2003; 69(2):142-3. PubMed ID: 17642861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial.
    Rigopoulos D; Gregoriou S; Kontochristopoulos G; Ifantides A; Katsambas A
    Mycoses; 2007 May; 50(3):193-5. PubMed ID: 17472615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.
    Lange DS; Richards HM; Guarnieri J; Humeniuk JM; Savin RC; Reyes BA; Hickman J; Pariser DM; Pariser RJ; Sherertz EF; Grossman RM; Gisoldi EM; Klausner MA
    J Am Acad Dermatol; 1998 Dec; 39(6):944-50. PubMed ID: 9843006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of ketoconazole versus selenium sulphide shampoo in pityriasis versicolor.
    Aggarwal K; Jain VK; Sangwan S
    Indian J Dermatol Venereol Leprol; 2003; 69(2):86-7. PubMed ID: 17642841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study.
    Di Fonzo EM; Martini P; Mazzatenta C; Lotti L; Alvino S
    Mycoses; 2008 Nov; 51(6):532-5. PubMed ID: 18422916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of oral and topical ketoconazole therapy in pityriasis versicolor.
    Nagpal VB; Jain VK; Aggarwal K
    Indian J Dermatol Venereol Leprol; 2003; 69(4):287-8. PubMed ID: 17642914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
    Yazdanpanah MJ; Azizi H; Suizi B
    Mycoses; 2007 Jul; 50(4):311-3. PubMed ID: 17576325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pityriasis versicolor alba.
    Thoma W; Krämer HJ; Mayser P
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):147-52. PubMed ID: 15752280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized, placebo-controlled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor.
    Faergemann J; Todd G; Pather S; Vawda ZF; Gillies JD; Walford T; Barranco C; Quiring JN; Briones M
    J Am Acad Dermatol; 2009 Dec; 61(6):971-6. PubMed ID: 19828211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole and itraconazole in pityriasis versicolor.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Dermatol Venereol Leprol; 1999; 65(5):216-8. PubMed ID: 20921662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of pityriasis versicolor in Adana, Turkey.
    Karakaş M; Turaç-Biçer A; Ilkit M; Durdu M; Seydaoğlu G
    J Dermatol; 2009 Jul; 36(7):377-82. PubMed ID: 19583685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Azole Antifungal in Treatment of Pityriasis Versicolor.
    Cam VT; Van TN; Hau KT; Huu DL; Minh PPT; Huu SN; Minh TN; Gandolfi M; Satolli F; Feliciani C; Tirant M; Vojvodic A; Lotti T
    Open Access Maced J Med Sci; 2019 Jan; 7(2):272-274. PubMed ID: 30745978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Missing granulocytic infiltrate in pityriasis versicolor--indication of specific anti-inflammatory activity of the pathogen?].
    Wroblewski N; Bär S; Mayser P
    Mycoses; 2005; 48 Suppl 1():66-71. PubMed ID: 15826291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
    Rog DJ; Nurmikko TJ; Young CA
    Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncommon cases of pityriasis versicolor.
    Romano C
    Parassitologia; 2008 Jun; 50(1-2):93-4. PubMed ID: 18693567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of ketoconazole in dogs--a retrospective study.
    Mayer UK; Glos K; Schmid M; Power HT; Bettenay SV; Mueller RS
    Vet Dermatol; 2008 Aug; 19(4):199-208. PubMed ID: 18547382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
    Poachanukoon O; Kitcharoensakkul M
    Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Malassezia species from pityriasis versicolor in Indonesia and its relationship with clinical characteristics.
    Krisanty RI; Bramono K; Made Wisnu I
    Mycoses; 2009 May; 52(3):257-62. PubMed ID: 18643886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.